Document is current
Any future updates will be listed below
-
Authors
Liao, Guolong
Long, Canling
Guo, Rui
Wang, Sushan
Han, Ruijuan
Yang, Jianhua
-
Funding
Funding for this research was provided by:
Shenzhen Science and Technology Innovation Program (JCYJ20220530162206012, JCYJ20230807141801002, JCYJ20240813160259020)
Longgang District Science and Technology Innovation Bureau Project (LGKCYLWS2022025)
Hospital and School Joint Fund (HUUF-ZD-202305, HUUF-MS-202308, HUUF-MS-202309)
- License Information
-
More Information
Article History
Received: 23 April 2025
Accepted: 19 August 2025
First Online: 26 August 2025
Declarations
:
: (1) Title of the approved project: Conditional Immortalization of Human Mesenchymal Stem Cells and Therapeutic Potential of Their Extracellular Vesicles Against Interstitial Cystitis; (2) Name of the institutional approval committee: The Animal Ethics Committee of Longgang District People’s Hospital of Shenzhen. (3) Approval number: 2024083DW. (4) Date of approval: 30/October/2024. The original source (Cyagen) of MSCs has confirmed that there was initial ethical approval for collection of human cells, and that the donors had signed informed consent. The original source (Pricella) of SV-HUC-1 cells has confirmed that there was initial ethical approval for collection of human cells, and that the donors had signed informed consent.
: All authors agree to publish this version of the article.
: The authors declare that they have no competing interests.
